{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:59:55Z","timestamp":1790805595437,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.xphs.2026.104333","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T22:14:30Z","timestamp":1778969670000},"page":"104333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rapamycin loaded lipid-polymer hybrid nanoparticles in a topical hydrogel for the treatment of psoriasis"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1439-1144","authenticated-orcid":false,"given":"Samarth","family":"Bhargava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7638-001X","authenticated-orcid":false,"given":"Abhay","family":"Tharmatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5054-5854","authenticated-orcid":false,"given":"Prabhjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9752-4319","authenticated-orcid":false,"given":"Hasratjot Singh","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8988-046X","authenticated-orcid":false,"given":"Murali Monohar","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3344-9579","authenticated-orcid":false,"given":"Anupama","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4174-7664","authenticated-orcid":false,"given":"Deepak","family":"Chitkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2026.104333_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1340677","article-title":"Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets","volume":"14","author":"Li","year":"2024","journal-title":"Front Immunol"},{"issue":"26","key":"10.1016\/j.xphs.2026.104333_bib0002","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.2174\/1381612829666230904150808","article-title":"Role of Th17 and IL-17 cytokines on inflammatory and auto-immune diseases","volume":"29","author":"Akhter","year":"2023","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.xphs.2026.104333_bib0003","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","article-title":"Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease","volume":"8","author":"Panwar","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.xphs.2026.104333_bib0004","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/0019-5154.123499","article-title":"mTOR signaling cascade in psoriatic disease: double kinase mTOR inhibitor a novel therapeutic target","volume":"59","author":"Raychaudhuri","year":"2014","journal-title":"Indian J Dermatol"},{"issue":"10","key":"10.1016\/j.xphs.2026.104333_bib0005","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/exd.13745","article-title":"Rapamycin ameliorates psoriasis by regulating the expression and methylation levels of tropomyosin via ERK1\/2 and mTOR pathways in vitro and in vivo","volume":"27","author":"Gao","year":"2018","journal-title":"Exp Dermatol"},{"issue":"9","key":"10.1016\/j.xphs.2026.104333_bib0006","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2340\/00015555-2724","article-title":"Blocking mTOR signalling with rapamycin ameliorates imiquimod-induced psoriasis in mice","volume":"97","author":"B\u00fcrger","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.xphs.2026.104333_bib0007","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.2147\/IJN.S26546","article-title":"Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process","volume":"6","author":"Hwang","year":"2011","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.xphs.2026.104333_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1333986","article-title":"Topical drug delivery strategies for enhancing drug effectiveness by skin barriers, drug delivery systems and individualized dosing","volume":"14","author":"Zhao","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.xphs.2026.104333_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2023.100165","article-title":"Lipid polymer hybrid nanoparticles as potent vehicles for drug delivery in cancer therapeutics","volume":"20","author":"Parveen","year":"2023","journal-title":"Med Drug Discov"},{"issue":"4","key":"10.1016\/j.xphs.2026.104333_bib0010","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1590\/S1984-82502012000400025","article-title":"In vitro skin penetration of clobetasol from lipid nanoparticles: drug extraction and quantitation in different skin layers","volume":"48","author":"Silva","year":"2012","journal-title":"Braz J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104333_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123742","article-title":"Novel approach for enhancing skin allograft survival by bioadhesive nanoparticles loaded with rapamycin","volume":"651","author":"Liu","year":"2024","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2026.104333_bib0012","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3390\/pharmaceutics14030569","article-title":"Mixed polymeric micelles for rapamycin skin delivery","volume":"14","author":"Le Guyader","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.xphs.2026.104333_bib60","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/s12967-025-06219-6","article-title":"Can breakthroughs in dermal and transdermal macromolecule delivery surmount existing barriers and revolutionize future therapeutics?","volume":"23","author":"Bhat","year":"2025","journal-title":"J Transl Med"},{"issue":"3","key":"10.1016\/j.xphs.2026.104333_bib0013","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3390\/pharmaceutics14030574","article-title":"Drug delivery strategies and biomedical significance of hydrogels: translational considerations","volume":"14","author":"Raina","year":"2022","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.xphs.2026.104333_bib0014","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3390\/pharmaceutics16040449","article-title":"Recent approaches for the topical treatment of psoriasis using nanoparticles","volume":"16","author":"Bodn\u00e1r","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104333_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120030","article-title":"Marriage of phospholipid and block copolymer in lipopolymersome hybrid structure for efficient tumor accumulation","volume":"591","author":"Zahiri","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104333_bib0016","article-title":"Synthesis of methoxy poly(ethylene glycol)-poly(\u03b5-caprolactone) diblock copolymers hybridized with DDAB cationic lipid as efficient nanocarriers for in vitro delivery of lycopene into MCF-7 cells","volume":"66","author":"Mennati","year":"2021","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2026.104333_bib0017","article-title":"A novel liposome-polymer hybrid nanoparticles delivering a multi-epitope self-replication DNA vaccine and its preliminary immune evaluation in experimental animals","volume":"35","author":"Zhao","year":"2020","journal-title":"Nanomedicine"},{"issue":"7","key":"10.1016\/j.xphs.2026.104333_bib0018","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/10837450.2022.2122506","article-title":"Hyperoside-loaded TPGS\/mPEG-PDLLA self-assembled polymeric micelles: preparation, characterization and in vitro\/in vivo evaluation","volume":"27","author":"Xia","year":"2022","journal-title":"Pharm Dev Technol"},{"issue":"7","key":"10.1016\/j.xphs.2026.104333_bib0019","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-021-02116-5","article-title":"Topical application of vitamin D3-loaded hybrid nanosystem to offset imiquimod-induced psoriasis","volume":"22","author":"Pukale","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2026.104333_bib0020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.actbio.2020.08.020","article-title":"Multi-component clobetasol-loaded monolithic lipid-polymer hybrid nanoparticles ameliorate imiquimod-induced psoriasis-like skin inflammation in swiss albino mice","volume":"115","author":"Pukale","year":"2020","journal-title":"Acta Biomater"},{"key":"10.1016\/j.xphs.2026.104333_bib0021","article-title":"Coenzyme Q10 loaded lipid-polymer hybrid nanoparticles in gel for the treatment of psoriasis-like skin condition","volume":"76","author":"Pukale","year":"2022","journal-title":"J Drug Deliv Sci Technol"},{"issue":"28","key":"10.1016\/j.xphs.2026.104333_bib0022","doi-asserted-by":"crossref","first-page":"20351","DOI":"10.1039\/D4RA02337D","article-title":"Lipo-polymeric nano-complexes for dermal delivery of a model protein","volume":"14","author":"Tharmatt","year":"2024","journal-title":"RSC Adv"},{"key":"10.1016\/j.xphs.2026.104333_bib0023","series-title":"Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs: Guidance for Industry","year":"2026"},{"key":"10.1016\/j.xphs.2026.104333_bib0024","series-title":"USP-NF General Chapter \u27e81911\u27e9 Rheometry","year":"2023"},{"issue":"9","key":"10.1016\/j.xphs.2026.104333_bib0025","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3390\/pharmaceutics12090820","article-title":"Rheology by design: a regulatory tutorial for analytical method validation","volume":"12","author":"Sim\u00f5es","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104333_bib0026","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejps.2018.11.014","article-title":"On-line rheological characterization of semi-solid formulations","volume":"128","author":"Qwist","year":"2019","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104333_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124398","article-title":"Therapeutic-driven framework for bioequivalence assessment of complex topical generic drug products","volume":"661","author":"Louren\u00e7o","year":"2024","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2026.104333_bib0028","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3390\/gels11121006","article-title":"Comparative evaluation of spreadability measurement methods for topical semisolid formulations: a scoping review","volume":"11","author":"Al-Barghouthy","year":"2025","journal-title":"Gels"},{"issue":"9","key":"10.1016\/j.xphs.2026.104333_bib0029","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"Van Der Fits","year":"2009","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.xphs.2026.104333_bib0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/ijp.IJP_506_19","article-title":"Development of a psoriatic-like skin inflammation rat model using imiquimod as an inducing agent","volume":"53","author":"Parmar","year":"2021","journal-title":"Indian J Pharmacol"},{"issue":"4","key":"10.1016\/j.xphs.2026.104333_bib0031","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4103\/0019-5154.113948","article-title":"A study of various histopathological features and their relevance in pathogenesis of psoriasis","volume":"58","author":"Chatterjee","year":"2013","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.xphs.2026.104333_bib0032","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2019.7596","article-title":"Immunohistochemical study of psoriatic plaques and perilesional skin in psoriasis vulgaris patients: a pilot study","author":"Morar","year":"2019","journal-title":"Exp Ther Med"},{"issue":"3","key":"10.1016\/j.xphs.2026.104333_bib0033","doi-asserted-by":"crossref","first-page":"203","DOI":"10.11613\/BM.2011.029","article-title":"Multiple comparison analysis testing in ANOVA","volume":"21","author":"McHugh","year":"2011","journal-title":"Biochem Med"},{"key":"10.1016\/j.xphs.2026.104333_bib0034","article-title":"Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis","volume":"5","author":"Sbidian","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.xphs.2026.104333_bib0035","article-title":"Polymer-hybrid nanoparticles: current advances in biomedical applications","volume":"131","author":"Soares","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.xphs.2026.104333_bib0036","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.3390\/ijms24032978","article-title":"Recent advancements in topical anti-psoriatic nanostructured lipid carrier-based drug delivery","volume":"24","author":"Patil","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.xphs.2026.104333_bib0037","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1450","article-title":"Stimuli-responsive liposomes for drug delivery","volume":"9","author":"Lee","year":"2017","journal-title":"WIREs Nanomed Nanobiotechnol"},{"key":"10.1016\/j.xphs.2026.104333_bib0038","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"10.1016\/j.xphs.2026.104333_bib0039","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/pol.20230941","article-title":"Facile synthesis of rapamycin-loaded PEG-b-PLA nanoparticles and their application in immunotherapy","volume":"62","author":"Li","year":"2024","journal-title":"J Polym Sci"},{"issue":"48","key":"10.1016\/j.xphs.2026.104333_bib0040","doi-asserted-by":"crossref","first-page":"55495","DOI":"10.1021\/acsami.2c13141","article-title":"In vitro and in vivo hydrolytic degradation behaviors of a drug-delivery system based on a blend of PEG and PLA copolymers","volume":"15","author":"Ng","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"issue":"8","key":"10.1016\/j.xphs.2026.104333_bib0041","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3390\/pharmaceutics14081593","article-title":"Preparation and study of solid lipid nanoparticles based on curcumin, resveratrol and capsaicin containing linolenic acid","volume":"14","author":"Cassano","year":"2022","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.xphs.2026.104333_bib0042","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3390\/pharmaceutics17081079","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers for anticancer phytochemical delivery: advances, challenges, and future prospects","volume":"17","author":"Jacob","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.xphs.2026.104333_bib0043","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5173(03)00229-1","article-title":"Physical and thermal characterisation of Precirol and Compritol as lipophilic glycerides used for the preparation of controlled-release matrix pellets","volume":"260","author":"Hamdani","year":"2003","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2026.104333_bib0044","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/1735-5362.235156","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages","volume":"13","author":"Mohammadi-Samani","year":"2018","journal-title":"Res Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2026.104333_bib0058","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1177\/08853282231223808","article-title":"Modulation of immunosuppressive effect of rapamycin via microfluidic encapsulation within PEG-PLGA nanoparticles","volume":"38","author":"Wu","year":"2023","journal-title":"J Biomater Appl"},{"key":"10.1016\/j.xphs.2026.104333_bib0045","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.2147\/DDDT.S264648","article-title":"Potential of nanoparticles as permeation enhancers and targeted delivery options for skin: advantages and disadvantages","volume":"14","author":"Ghasemiyeh","year":"2020","journal-title":"Drug Des Devel Ther"},{"issue":"10","key":"10.1016\/j.xphs.2026.104333_bib0046","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/s41557-021-00752-9","article-title":"Electrostatic co-assembly of nanoparticles with oppositely charged small molecules into static and dynamic superstructures","volume":"13","author":"Bian","year":"2021","journal-title":"Nat Chem"},{"issue":"1","key":"10.1016\/j.xphs.2026.104333_bib0047","doi-asserted-by":"crossref","DOI":"10.1186\/1749-8090-6-69","article-title":"Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts","volume":"6","author":"Zou","year":"2011","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.xphs.2026.104333_bib0048","doi-asserted-by":"crossref","DOI":"10.1039\/D5BM00555H","article-title":"Development of rapamycin-loaded PLGA nanoparticles for treating retinopathy of prematurity","author":"Shi","year":"2025","journal-title":"Biomater Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104333_bib0049","article-title":"In-vitro release of rapamycin from a thermosensitive polymer for the inhibition of vascular smooth muscle cell proliferation","volume":"1","author":"Zhu","year":"2009","journal-title":"J Bioequiv Bioavailab"},{"issue":"1","key":"10.1016\/j.xphs.2026.104333_bib0050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-chembioeng-073009-100847","article-title":"Polymers for drug delivery systems","volume":"1","author":"Liechty","year":"2010","journal-title":"Annu Rev Chem Biomol Eng"},{"issue":"1","key":"10.1016\/j.xphs.2026.104333_bib0051","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/gels10010045","article-title":"Novel therapeutic hybrid systems using hydrogels and nanotechnology: a focus on nanoemulgels for the treatment of skin diseases","volume":"10","author":"Sghier","year":"2024","journal-title":"Gels"},{"issue":"4","key":"10.1016\/j.xphs.2026.104333_bib0052","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3390\/gels7040255","article-title":"Relationship between structure and rheology of hydrogels for various applications","volume":"7","author":"Stojkov","year":"2021","journal-title":"Gels"},{"issue":"7","key":"10.1016\/j.xphs.2026.104333_bib0059","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3390\/gels10070420","article-title":"Influence of sonication on the molecular characteristics of Carbopol and its rheological behavior in microgels","volume":"10","author":"P\u00e9rez-Gonz\u00e1lez","year":"2024","journal-title":"Gels"},{"issue":"3","key":"10.1016\/j.xphs.2026.104333_bib0053","doi-asserted-by":"crossref","DOI":"10.1007\/s11051-023-05690-w","article-title":"Structural parameters of nanoparticles affecting their toxicity for biomedical applications: a review","volume":"25","author":"Abbasi","year":"2023","journal-title":"J Nanopart Res"},{"issue":"11","key":"10.1016\/j.xphs.2026.104333_bib0054","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1093\/rheumatology\/ket272","article-title":"Normative values for the Bath Ankylosing Spondylitis Metrology Index in a UK population","volume":"52","author":"Chilton-Mitchell","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.xphs.2026.104333_bib0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: from keratinocyte perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.xphs.2026.104333_bib0056","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/PTT.S294173","article-title":"Key signaling pathways in psoriasis: recent insights from antipsoriatic therapeutics","volume":"11","author":"Ben Abdallah","year":"2021","journal-title":"Psoriasis"},{"issue":"11","key":"10.1016\/j.xphs.2026.104333_bib0057","doi-asserted-by":"crossref","first-page":"10137","DOI":"10.1021\/acsabm.5c01478","article-title":"Lipopolymeric nanoplex-mediated CRISPR\/Cas9 delivery for VEGF-A knockdown in psoriatic angiogenesis","volume":"8","author":"Tharmatt","year":"2025","journal-title":"ACS Appl Bio Mater"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926001826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926001826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:29:00Z","timestamp":1790803740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926001826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0022354926001826"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104333","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapamycin loaded lipid-polymer hybrid nanoparticles in a topical hydrogel for the treatment of psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}],"article-number":"104333"}}